Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterologystudy published on April 8.
Blocking macropinocytosis reshapes the tumor microenvironment to be less fibrous and to allow more access to immune cells, according to a preclinical study of pancreatic tumors conducted by scientists at Sanford Burnham Prebys, an NCI-designated Cancer Center.
